Knockdown of hTERT Alters Biophysical Properties of K562 Cells Resulting in Decreased Migration Rate In Vitro

Cell Biochemistry and Biophysics

Volumn 61, Issue 3, 2011, Pages 595-603

  Zhang, Yingyu ^a,b   Chen, Xiaopeng ^c   Xu, Xiaofeng ^d   Wang, Xianwei ^a   Wang, Xifu ^e   Yuan, Guihong ^a   Sun, Dagong ^a   Ka, Weibo ^a   He, Dongqi ^a   Wen, Zongyao ^a   Yao, Weijuan ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

^c CHENGDE MEDICAL COLLEGE   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e PEKING UNIVERSITY SHOUGANG HOSPITAL   (China)

Author keywords

Biophysics; K562; Knockdown; Migration; Telomerase

Indexed keywords

ACTIN; CALCIUM; CD71 ANTIGEN; COMPLEMENTARY DNA; LEUKOCYTE ANTIGEN; TELOMERASE; TRANSFERRIN RECEPTOR;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; CELL STRAIN K 562; CYTOPLASM; ELASTICITY; GENE EXPRESSION REGULATION; GENE SILENCING; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; VISCOSITY;

ACTINS; ANTIGENS, CD; APOPTOSIS; CALCIUM; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CYTOPLASM; DNA, ANTISENSE; DNA, COMPLEMENTARY; ELASTICITY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENETIC VECTORS; HUMANS; K562 CELLS; RECEPTORS, TRANSFERRIN; TELOMERASE; TRANSFECTION; VISCOSITY;

EID: 81155133886     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-011-9242-0     Document Type: Article

References (35)

1. Ahmed, A., & Tollefsbol, T. (2003). Telomeres, telomerase, and telomerase inhibition: Clinical implications for cancer. Journal of the American Geriatrics Society, 51, 116-122.
2. Akiyama, M., Hideshima, T., Munshi, N. C., & Anderson, K. C. (2002). Telomerase inhibitors as anticancer therapy. Current Medicinal Chemistry Anticancer Agents, 2, 567-575.
3. Akiyama, M., Yamada, O., Kanda, N., Akita, S., Kawano, T., Ohno, T., et al. (2002). Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors. Cancer Letters, 178, 187-197.
4. Blackburn, E. H. (2005). Telomeres and telomerase: Their mechanisms of action and the effects of altering their functions. FEBS Letters, 579, 859-862.
5. Blasco, M. A. (2005). Mice with bad ends: Mouse models for the study of telomeres and telomerase in cancer and aging. EMBO Journal, 24, 1095-1103.
6. Camp, J. P., & Capitano, A. T. (2005). Size-dependent mobile surface charge model of cell electrophoresis. Biophysical Chemistry, 113, 115-122.
7. Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. E., Greider, C. W., Harley, C. B., et al. (1992). Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO Journal, 11, 1921-1929.
8. Deng, Y., & Chang, S. (2007). Role of telomeres and telomerase in genomic instability, senescence and cancer. Laboratory Investigation, 87, 1071-1076.
9. Dikmen, Z. G., Gellert, Z. G., Jackson, S., Gryaznov, S., Tressler, R., Dogan, P., et al. (2005). In vivo inhibition of lung cancer by GRN163L: A novel human telomerase inhibitor. Cancer Research, 65, 7866-7873.
10. Garib, V., Lang, K., Niggemann, B., Zänker, K. S., Brandt, L., & Dittmar, T. (2005). Propofol-induced calcium signalling and actin reorganization within breast carcinoma cells. European Journal of Anaesthesiology, 22(8), 609-615.
11. Gu, L., Fang, Y. H., Wang, Y., Yao, W. J., Sun, D. G., Ka, W. B., et al. (2005). TFAR19 gene changes the biophysical properties of murine erythroleukemia cells. Cell Biochemistry and Biophysics, 43(3), 355-363.
12. Gu, L., Tang, Z., He, D., Ka, W., Sun, D., & Wen, Z. (2007). Effects of TFAR19 gene on the in vivo biorheological properties and pathogenicity of mouse erythroleukemia cell line MEL. Science China C. Life Science, 50, 111-119.
13. Gui, Y., Yeganeh, M., Ramanathan, S., Leblanc, C., Pomerleau, V., Ferbeyre, G., Saucier, C., & Ilangumaran, S. (in press). SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes. Journal of Hepatology.
14. Guo, J., Zhang, L., Jiang, Y., Zeng, Z., Sun, D., Ka, W., et al. (2005). Effects of Compound Dan-shen Root Dropping Pill on hemorheology in high-fat diet induced hyperlipidemia in dogs. Clinical Hemorheology Microcirculation, 32, 19-30.
15. Herbert, B., Pitts, A. E., Baker, S. I., Hamilton, S. E., Wright, W. E., Shay, J. W., et al. (1999). Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proceedings of the National Academy of Sciences of the United States of America, 96, 14276-14281.
16. Iwama, H., Ohyashiki, K., Ohyashiki, J. H., Hayashi, S., Kawakubo, K., Shay, J. W., et al. (1997). The relationship between telomere length and therapy-associated cytogenetic responses in patients with chronic myeloid leukemia. Cancer, 79, 1552-1560.
17. Jiang, Y., Chen, K., Tang, Z., Zeng, Z., Yao, W., Sun, D., et al. (2006). TRAIL gene reorganizes the cytoskeleton and decreases the motility of human leukemic Jurkat cells. Cell Motility and the Cytoskeleton, 63, 471-482.
18. Kremenetskaia, O. S., Logacheva, N. P., Baryshnikov, A. I., Chumakov, P. M., & Kopnin, B. P. (1996). The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells. Tsitologiia, 38, 1280-1293.
19. Lee, B. J., Wang, S. G., Choi, J. S., Lee, J. C., Goh, E. K., & Kim, M. G. (2006). The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patients. American Journal of Clinical Oncology, 29, 163-167.
20. LeGal, J. M., Morjani, H., Fardel, O., Guillouzo, A., & Manfait, M. (1994). Conformational changes in membrane proteins of multidrug-resistant K562 and primary rat hepatocyte cultures as studied by Fourier transform infrared spectroscopy. Anticancer Research, 14, 1541-1548.
21. 2+ homeostasis. Cancer Chemotherapy and Pharmacology, 55, 79-90.
22. Moh, M. C., & Shen, S. (2009). The roles of cell adhesion molecules in tumor suppression and cell migration: A new paradox. Cell Adhesion and Migration, 3(4), 334-336.
23. Mu, J., & Wei, L. X. (2002). Telomere and telomerase in oncology. Cell Research, 12, 1-7.
24. Nathan, I., Ben-Valid, I., Henzel, R., Masalha, H., Baram, S. N., Dvilansky, A., et al. (1998). Alterations in membrane lipid dynamics of leukemic cells undergoing growth arrest and differentiation: Dependency on the inducing agent. Experimental Cell Research, 239, 442-446.
25. Obchoei, S., Wongkhan, S., Wongkham, C., Li, M., Yao, Q., & Chen, C. (2009). Cyclophilin A: Potential functions and therapeutic target for human cancer. Medical Science Monitor, 15(11), RA221-RA232.
26. Ohyashiki, K., Ohyashiki, J. H., Iwama, H., Hayashi, S., Shay, J. W., & Toyama, K. (1997). Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression. Leukemia, 11, 190-194.
27. Okegawa, T., Li, Y., Pong, R. C., & Hsieh, J. T. (2002). Cell adhesion proteins as tumor suppressors. Journal of Urology, 167, 1836-1843.
28. Roth, A., Vercauteren, S., Sutherland, H. J., & Lansdorp, P. M. (2003). Telomerase is limiting the growth of acute myeloid leukemia cells. Leukemia, 17, 2410-2417.
29. Wang, E. S., Wu, K., Chin, A. C., Chen-Kiang, S., Pongracz, K., Gryaznov, S., et al. (2004). Telomerase inhibition with an oligonucleotide telomerase template antagonist: In vitro and in vivo studies in multiple myeloma and lymphoma. Blood, 103, 258-266.
30. Yamada, O., Akiyama, M., Kawauchi, K., Adachi, T., Yamada, H., Kanda, N., et al. (2003). Overexpression of telomerase confers a survival advantage through suppression of TRF1 gene expression while maintaining differentiation characteristics in K562 cells. Cell Transplantation, 12, 365-377.
31. Yao, W., Chen, K., Wang, X., Xie, L., Wen, Z., Yan, Z., et al. (2002). Influence of TRAIL gene on biomechanical properties of the human leukemic cell line, Jurkat. Journal of Biomechanics, 35, 1659-1663.
32. Yao, W., Gu, L., Sun, D., Ka, W., Wen, Z., & Chien, S. (2003). Wild type p53 gene causes reorganization of cytoskeleton and, therefore, the impaired deformability and difficult migration of murine erythroleukemia cells. Cell Motility and the Cytoskeleton, 56, 1-12.
33. Zeng, Z., Yao, W., Xu, X., Xu, G., Long, J., Wang, X., et al. (2009). Hepatocellular carcinoma cells deteriorate the biophysical properties of dendritic cells. Cell Biochemistry and Biophysics, 55, 33-43.
34. Zhang, Y., & He, D. M. (2002). Effect of antisense-hTERT mRNA oligodeoxynucleotide on telomerase activity of leukemic cells. Cell Biology International, 26, 427-431.
35. Zhang, Y., Yao, W., Zeng, Z., Wang, X., Sun, D., Ka, W., et al. (2007). Exogenous wild-type p53 gene improved survival of nude mice injected with murine erythroleukemia cell line through amelioration of hemorheological changes. Microcirculation, 14, 155-166.